Markovic, Olivera <br/><br/>
Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL).  [electronic resource] 

 -  European journal of haematology  Mar 2011 
 - 246-55 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2010.01567.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Apoptosis<br/>CASP8 and FADD-Like Apoptosis Regulating Protein--metabolism<br/>Caspase 3--metabolism<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Inhibitor of Apoptosis Proteins<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Microtubule-Associated Proteins--metabolism<br/>Middle Aged<br/>Multivariate Analysis<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Survivin<br/>Vincristine--administration & dosage<br/>X-Linked Inhibitor of Apoptosis Protein--metabolism<br/>Young Adult<br/>fas Receptor--metabolism